Rodríguez F., Caruana P., De la Fuente N., Español P., Gámez M., Balart J., Llurba E., Rovira R., Ruiz R., Martín-Lorente C., Corchero J.L., Céspedes M.V.. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges. Biomolecules. 2022; 12(6)DOI:10.3390/biom12060784. PMID:35740909. IF:5.500(Q1/3D).

Jimenez-Quevedo, P, Nombela-Franco, L, Munoz-Garcia, E, del Valle-Fernandez, R, Trillo, R, Hernandez, JMD, Salido, L, Elizaga, J, Ojeda, S, Gila, JS, del Blanco, BG, Berenguer, A, Lasa-Larraya, G, Carrillo, CU, Albarran, A, Ruiz-Salmeron, R, Moreu, J, Gheorghe, L, Arzamendi, D, Yanes-Bowden, G, Diaz, J, Perez-Moreiras, I, Artaiz, M, Vaquerizo, B, Cruz-Gonzalez, I, Ruiz-Quevedo, V, Blanco-Mata, R, Baz, JA, Villa, M, de Salazar, AO, Tascon-Quevedo, V, Casellas, S, Moreno, R. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(6)DOI:10.1016/j.rec.2021.07.019. PMID:34711513. IF:5.900(Q1/3D).

Campos NS, Bluth T, Hemmes SNT, Librero J, Pozo N, Ferrando C, Ball L, Mazzinari G, Pelosi P, Gama de Abreu M, Schultz MJ, Serpa Neto A, Unzueta C., Moral M.V., Sabate, S, Cegarra V., PROVE Network. Intraoperative positive end-expiratory pressure and postoperative pulmonary complications: a patient-level meta-analysis of three randomised clinical trials.. BRITISH JOURNAL OF ANAESTHESIA. 2022; 128(6)DOI:10.1016/j.bja.2022.02.039. PMID:35431038. IF:9.800(Q1/1D).

Cervan-Martin, M, Bossini-Castillo, L, Guzman-Jimenez, A, Rivera-Egea, R, Garrido, N, Lujan, S, Romeu, G, Santos-Ribeiro, S, Castilla, JA, Gonzalvo, MC, Clavero, A, Vicente, FJ, Maldonado, V, Gonzalez-Munoz, S, Rodriguez-Martin, I, Burgos, M, Jimenez, R, Pinto, MG, Pereira, I, Nunes, J, Sanchez-Curbelo, J, Lopez-Rodrigo, O, Pereira-Caetano, I, Marques, PI, Carvalho, F, Barros, A, Bassas, L, Seixas, S, Goncalves, J, Larriba, S, Lopes, AM, Carmona, FD, Palomino-Morales, RJ. Common Variation in the PIN1 Locus Increases the Genetic Risk to Suffer from Sertoli Cell-Only Syndrome. Journal of Personalized Medicine. 2022; 12(6)DOI:10.3390/jpm12060932. PMID:35743717. IF:3.508(Q2/4D).